[SRNE] QoQ Quarter Result on 30-Jun-2012 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
14-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -4.08%
YoY- 13.33%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 134 122 135 217 110 128 92 28.46%
PBT -2,522 -3,236 -1,241 -943 -906 -3,236 -445 217.54%
Tax 2 -3,090 4 4 3 -2,474 2 0.00%
NP -2,522 -1,755 -1,241 -943 -906 -762 -702 134.38%
Tax Rate - - - - - - - -
Total Cost 2,656 1,877 1,376 1,160 1,016 890 794 123.50%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin -1,881.46 -1,438.58 -922.81 -434.35 -822.64 -595.84 -765.39 82.04%
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
EPS -0.20 -0.14 -0.10 -0.08 -0.09 -0.07 -0.07 101.22%
EPS Diluted -0.20 -0.14 -0.10 -0.08 -0.09 -0.07 -0.07 101.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.